CD8A and neoplasm: They could demonstrate that long-term survivors (more than six years for 82 patients) exhibited a significantly higher number of neoantigen reactive and TCR repertoire diverse CD8+ T cells, which were thought to maintain the tumors with a median of 38 neoantigens per tumor under control [10].